BLUESKEYE AI uses machine learning to objectively measure social, emotional, and medically relevant expressed behavior, better than ever before.

The company aims to create the most-used technology for ethical machine understanding of face and voice behavior, trusted to measure the mind through ubiquitously available, affordable technology, such as mobile phones and tablets.

Blueskeye's technology is clinical-grade and has been extensively tested in clinical trials to prove its efficacy and safety.

A spin-out from The University of Nottingham's School of Computer Science, Blueskeye received 3.4 million in venture capital funding led by XTX Ventures in October 2022.

Founded in 2019 by Professor Michel Valstar to commercialize research on Human Behavior Understanding; Professor Valstar is a renowned expert in machine learning, computer vision, and facial expression analysis with over 22 years of experience and over 19,000 citations in peer-reviewed publications.

The company employs over 30 people, including 10 PhDs, and values diversity and a collaborative culture.

Steve Cliffe is the CEO, a seasoned technology entrepreneur and business advisor with a track record in marketing, sales, and business model development.

Anthony Brown is a founder and CTO with a PhD in Computer Science and extensive experience in edge computing, privacy-preserving AI, and machine learning.

Michel Valstar, founder, Chief Evangelist, and Scientific Officer (CESO), is an Honorary Professor at the University of Nottingham and a thought leader in affective computing.

The leadership team also includes Charlie Alexander (Chief Commercial Officer), Sarah Wright (VP Business Development), John Michaelis (Go To Market & Early Adoption), and others.